FDA Raises Safety Concerns With Hep B Vaccine
The U.S. Food and Drug Administration raised safety concerns with Dynavax Technology Corp.'s hepatitis B vaccine Heplisav-B, saying that there were more deaths and serious cardiac events seen in patients taking...To view the full article, register now.
Already a subscriber? Click here to view full article